Related Experiment Videos
Importance of adequate initial antimicrobial therapy
1College of Medicine, University of Florida, Gainesville, FL 32610, USA. ramphr@medmac.ufl.edu
Chemotherapy
|June 28, 2005
Summary
Appropriate antibiotic therapy, particularly timely administration based on susceptibility, significantly improves outcomes in serious infections like bacteremia. While conclusive data for nosocomial pneumonia is limited, most evidence supports its crucial role in patient survival.
Area of Science:
- Infectious Diseases
- Clinical Pharmacology
- Critical Care Medicine
Background:
- The established principle of appropriate antibiotic therapy for serious infections is debated, especially concerning nosocomial pneumonia.
- Recent data on antibiotic therapy adequacy and patient outcomes require review.
Purpose of the Study:
- To review recent data on the adequacy of antibiotic therapy and its impact on outcomes in serious infections.
- To evaluate the role of appropriate antibiotic therapy in bacteremia and nosocomial pneumonia.
Main Methods:
- A literature search was conducted for articles published between 1997 and 2004.
- Articles focusing on appropriate/inappropriate antibiotic therapy, adequate therapy, antibiotic resistance, and delayed therapy were identified and data abstracted.
Main Results:
- Appropriate and timely antibiotic therapy strongly correlates with improved outcomes in bacteremia, with exceptions noted for specific pathogens and high therapy appropriateness rates.
- Data for nosocomial pneumonia are less conclusive, with some patient subsets confounding results, though most studies indicate a benefit from appropriate therapy.
- The role of specific antibiotic classes, like carbapenems versus cephalosporins for extended-spectrum beta-lactamase-producing enteric bacteria, requires further investigation.
Conclusions:
- Appropriate antibiotic therapy is dimensionally complex, with timing and susceptibility-based selection being key determinants of improved outcomes in most serious infections.
- Dosing intervals and dose magnitude are also critical but less exhaustively studied factors influencing patient outcomes.
- Future strategies should consider 'resistance'-proof antibiotics for empiric therapy to potentially enhance patient outcomes.